SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017973
Filing Date
2019-05-09
Accepted
2019-05-09 16:07:14
Documents
79
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tbio-10q_20190331.htm 10-Q 2236822
2 EX-10.1 tbio-ex101_217.htm EX-10.1 94842
3 EX-31.1 tbio-ex311_6.htm EX-31.1 18801
4 EX-31.2 tbio-ex312_9.htm EX-31.2 18398
5 EX-32.1 tbio-ex321_7.htm EX-32.1 9287
6 EX-32.2 tbio-ex322_8.htm EX-32.2 9495
  Complete submission text file 0001564590-19-017973.txt   7780701

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tbio-20190331.xml EX-101.INS 1555035
8 XBRL TAXONOMY EXTENSION SCHEMA tbio-20190331.xsd EX-101.SCH 57999
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tbio-20190331_cal.xml EX-101.CAL 51358
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tbio-20190331_def.xml EX-101.DEF 231790
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbio-20190331_lab.xml EX-101.LAB 473012
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbio-20190331_pre.xml EX-101.PRE 382409
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Filer) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38550 | Film No.: 19810546
SIC: 2836 Biological Products, (No Diagnostic Substances)